Company news
Evogene Ltd. (NASDAQ:EVGN) news
Every Evogene Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly...
August 25, 2026
Evogene Reports Second Quarter and First Half 2026 Financial Results
August 18, 2026
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
August 14, 2026
Evogene Schedules Second Quarter 2026 Financial Results Release
July 30, 2026
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipide...
July 22, 2026
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
July 15, 2026
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Dr...
July 8, 2026
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discove...
June 24, 2026
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
June 9, 2026
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination...
June 2, 2026
Evogene Reports First Quarter 2026 Financial Results
May 20, 2026
Evogene to Present at the 24th Schrödinger European User Group Meeting
May 12, 2026
Evogene Schedules First Quarter 2026 Financial Results Release
May 7, 2026
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
April 2, 2026
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable ...
March 31, 2026
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
March 9, 2026
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
Evogene Releases CEO Letter to Shareholders
February 25, 2026
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
February 19, 2026
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
February 17, 2026
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammato...
February 11, 2026
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
February 10, 2026
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
February 10, 2026
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
February 9, 2026
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for ...
February 4, 2026
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinatin...
January 7, 2026
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
December 30, 2025
Evogene Reports Third Quarter 2025 Financial Results
November 20, 2025
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
November 11, 2025
Evogene Schedules Third Quarter 2025 Financial Results Release
November 6, 2025
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
August 28, 2025
Evogene Reports Second Quarter 2025 Financial Results
August 19, 2025
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
August 12, 2025
Evogene Schedules Second Quarter 2025 Financial Results Release
July 29, 2025
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
July 8, 2025
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
June 10, 2025
Evogene Reports First Quarter 2025 Financial Results
May 21, 2025
Evogene Schedules First Quarter 2025 Financial Results Release
May 8, 2025
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
April 21, 2025
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
March 6, 2025
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
March 6, 2025
Evogene Schedules Fourth Quarter 2024 Financial Results Release
February 20, 2025
Evogene Reports Third Quarter 2024 Financial Results
November 21, 2024
Evogene Schedules Third Quarter 2024 Financial Results Release
November 7, 2024
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
October 31, 2024
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
August 23, 2024
Evogene Reports Second Quarter 2024 Financial Results
August 22, 2024
Evogene Schedules Second Quarter 2024 Financial Results Release
August 12, 2024
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
August 12, 2024
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
July 23, 2024